跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
METASTRON strontium(89Sr) chloride 150 MBq/4mL injection - TGA Drug Approval Details
Approvals
/
TGA
/
METASTRON strontium(89Sr) chloride 150 MBq/4mL injection
Approved
STANDARD
METASTRON strontium(89Sr) chloride 150 MBq/4mL injection
GE Healthcare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
ef64c76e32a79a1e
Company
GE Healthcare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ef64c76e32a79a1e
Product Name
METASTRON strontium(89Sr) chloride 150 MBq/4mL injection
Artg Id
42958
Artg Name
METASTRON strontium(89Sr) chloride 150 MBq/4mL injection vial
Sponsor
GE Healthcare Australia Pty Ltd
Company Detail Path
/organization/ge-healthcare-australia-pty-limited
Artg Date
1993-07-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/798e91cc59c55505f96267fd326ed481.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c20aca4ceb2a5c0928d23700f4ddac63.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
ef64c76e32a79a1e
Type
Standard
Back to TGA Approvals